If you wish to submit a question, click here. Questions with a common theme
will be selected and answered comprehensively by our Distinguished Faculty
members. Previously answered questions will be archived for your reference.

To view archived responses, click here.

Abraham Morgentaler, MD
Associate Clinical Professor
Urologic Surgery
Harvard Medical School
Boston, Massachusetts

Jacob Rajfer, MD
Professor of Urology
University of California at Los Angeles
Chief of Urology
Harbor-UCLA Medical Center
Torrance, California

  • Endocrinologists, urologists, primary care physicians, cardiologists, and specialists interested in the management and treatment of hypogonadism
  • Endocrinology/urology nurses, nurse practitioners and physician assistants, diabetologists, clinicians who treat HIV/AIDS, psychologists and sex therapists, managed-care clinicians, and clinical pharmacists interested in the management and treatment of hypogonadism

The goal of this activity is to examine whether men living with localized prostate cancer and hypogonadism are candidates for treatment with testosterone therapy.

Patient outcomes could be measurably improved if physicians were better able to…

  1. Examine current data on the relationship between exogenous testosterone therapy and prostate health
  2. Review recent studies evaluating the effect of testosterone therapy on the prostate

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Annenberg Center for Health Sciences at Eisenhower and CogniMed Inc. The Annenberg Center is accredited by the ACCME to provide continuing medical education for physicians.

The Annenberg Center for Health Sciences at Eisenhower designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

There is no charge for this activity. Statements of Credit will be provided by mail following activity participation and upon completion and electronic submission of the evaluation and posttest to CogniMed Inc. A link to the evaluation and posttest is provided upon completion of the activity. Please allow 4 to 6 weeks for the delivery of your statement.

It is the policy of the Annenberg Center to ensure fair balance, independence, objectivity, and scientific rigor in all programming. All faculty participating in sponsored programs are expected to identify and reference off-label product use and disclose any significant relationships with those supporting the activity or any others whose products or services are discussed. The faculty for this activity have disclosed that there will be discussion about the use of products for non–FDA-approved indications.

In accordance with the Accreditation Council for Continuing Medical Education standards, parallel documents from other accrediting bodies, and Annenberg Center policy, the following disclosures have been made:

All staff at the Annenberg Center for Health Sciences at Eisenhower have nothing to disclose.

All staff at CogniMed Inc. have nothing to disclose.

Abraham Morgentaler, MD, receives research support from Auxilium Pharmaceuticals, Inc.; Endo Pharmaceuticals; GlaxoSmithKline; and Slate Pharmaceuticals, Inc. He is a consultant for and/or serves on the advisory boards of Abbott Laboratories, Endo Pharmaceuticals, Pfizer Inc., Slate Pharmaceuticals, Inc.

Jacob Rajfer, MD, receives research support from Allergan, Inc., and serves on the speakers bureau of Auxilium Pharmaceuticals, Inc.

The ideas and opinions presented in this educational activity are those of the faculty and do not necessarily reflect the views of the Annenberg Center and/or its agents. As in all educational activities, we encourage the practitioners to use their own judgment in treating and addressing the needs of each individual patient, taking into account that patient's unique clinical situation. The Annenberg Center disclaims all liability and cannot be held responsible for any problems that may arise from participating in this activity or following treatment recommendations presented.

This activity is supported by an independent educational grant provided by Endo Pharmaceuticals.

This activity is a Clinical Consult and consists of a question and two-part response. Successful completion is achieved by reading the material, reflecting on its implications in your practice, and completing the assessment component.

The estimated time to complete this activity is 0.5 hour.

This activity was originally released January 31, 2012, and is eligible for credit through January 31, 2013.

This piece was written by a medical writer and reviewed by faculty members. Faculty have final editorial control over the piece.

© 2012 CogniMed Inc. All rights reserved.                       TU14137/ACHS 4972                       January 2012